Stem Cell Science
“From now on, everything I 'm going to talk about is true. Some may be unbelievable, but it's all true. The fact that Shin-ichi Nishikawa, Hitoshi Niwa, and the late Yoshiki Sasai of the stem cell research team of RIKEN, which was the top scientific institution in Japan, was involved has been said to be a big problem. The STAP cell group (Shin-ichi Nishikawa, Hitoshi Niwa, late Yoshiki Sasai) has discovered a fact that is usually not known, that is, a paper forgery fraud executed by the stem cell research team of Science and RIKEN. Another paper-forgery scam that was involved in front of the cell. It's a terrifying world. People who do the terrible things hidden behind the word patient salvation. Is it really a Japanese story?
We have been slandered by nurses at National Defense Medical College Hospital and Douglas Sipp at RIKEN since 2008. It is a slander by the staff of the stem cell research team of RIKEN, the highest institution in the country. The police don't move either. Meanwhile, "The police will not move. I felt it was time for us to talk about the damage we suffered, so we decided to talk about everything.
This is all true.
The fact that the reason why Stemcell Science could not be listed was "due to the fraudulent thesis forging by the former management and RIKEN" was that JAFCO, an investment company affiliated with Nomura Securities, attended the board meeting as an observer. I knew all the facts because I was there. (Recording tape available) JAFCO tells shareholders from his own mouth. However, in order to explain the request for the return of the representative seal, it was the first time from the person in charge at the meeting with JAFCO's managing director that there are still many shareholders who do not know the facts. So, I explained using this homepage.
There is a lot of evidence (recording tapes and proof emails) that is true of what I am saying, but of these, I will only disclose the evidence that an American lawyer has told me to disclose. Others will be disclosed in an American trial.
Stem Cell Science
“From now on, everything I 'm going to talk about is true. Some may be unbelievable, but it's all true. The fact that Shin-ichi Nishikawa, Hitoshi Niwa, and the late Yoshiki Sasai of the stem cell research team of RIKEN, which was the top scientific institution in Japan, was involved has been said to be a big problem. The STAP cell group (Shin-ichi Nishikawa, Hitoshi Niwa, late Yoshiki Sasai) has discovered a fact that is usually not known, that is, a paper forgery fraud executed by the stem cell research team of Science and RIKEN. Another paper-forgery scam that was involved in front of the cell. It's a terrifying world. People who do the terrible things hidden behind the word patient salvation. Is it really a Japanese story?
We have been slandered by nurses at National Defense Medical College Hospital and Douglas Sipp at RIKEN since 2008. It is a slander by the staff of the stem cell research team of RIKEN, the highest institution in the country. The police don't move either. Meanwhile, "The police will not move. I felt it was time for us to talk about the damage we suffered, so we decided to talk about everything.
This is all true.
The fact that the reason why Stemcell Science could not be listed was "due to the fraudulent thesis forging by the former management and RIKEN" was that JAFCO, an investment company affiliated with Nomura Securities, attended the board meeting as an observer. I knew all the facts because I was there. (Recording tape available) JAFCO tells shareholders from his own mouth. However, in order to explain the request for the return of the representative seal, it was the first time from the person in charge at the meeting with JAFCO's managing director that there are still many shareholders who do not know the facts. So, I explained using this homepage.
There is a lot of evidence (recording tapes and proof emails) that is true of what I am saying, but of these, I will only disclose the evidence that an American lawyer has told me to disclose. Others will be disclosed in an American trial.
